Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)

Market Cap	101.19B
Revenue (ttm)	205.78B
Net Income (ttm)	12.83B
Shares Out	14.04M
EPS (ttm)	914.02
PE Ratio	7.89
Forward PE	n/a
Dividend	100.00 (1.38%)
Ex-Dividend Date	Dec 27, 2024

Volume	21,299
Average Volume	46,606
Open	7,160.00
Previous Close	7,220.00
Day's Range	7,140.00 - 7,250.00
52-Week Range	6,180.00 - 9,610.00
Beta	0.47
RSI	41.91
Earnings Date	Sep 1, 2025

About Daehan Nupharm

Daehan Nupharm Co.,Ltd. manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally. It offers pharmaceuticals drugs for cardiovascular, endocrine system, neuropsychiatric, gastrointestinal, respiratory system, antipyretic, analgesic, anti-inflammatory, anti-infective, musculoskeletal, osteoporosis, anti-cancer, urogenital system, antifungal, antiviral, hormones, dermatologic, central nervous system, anticonvulsive, amino acid, anesthetic, antiobesity, and others; vitamins; and inorganic products. The compa...

• Industry: Pharmaceutical Preparations
• Founded: 1984
• Employees: 228
• Stock Exchange: KOSDAQ
• Ticker Symbol: 054670

Financial Performance

In 2024, Daehan Nupharm's revenue was 202.19 billion, a decrease of -1.00% compared to the previous year's 204.22 billion. Earnings were 15.47 billion, an increase of 23.33%.